Xilio Development Valuation

XLO Stock  USD 7.14  -0.02  -0.28%   
Xilio Development is trading at $7.14, while our valuation model places fair value closer to $7.89 per share. On that basis, the stock looks undervalued. The estimate draws on Xilio Development fundamentals, including return on assets of -26%, profit margin of -1.84%, and current valuation of $-59.03M, together with its technical indicators and probability of bankruptcy. The valuation case for Xilio Development is shaped mainly by:
 Price Book
5.2438
 Enterprise Value
-59 M
 Enterprise Value Ebitda
-0.11
 Price Sales
0.0842
 Enterprise Value Revenue
1.9535
Undervalued
Today
7.14
At the moment, Xilio Development's price fluctuation remains Stable. The real value model for Xilio Development currently uses a 3 months horizon. A longer horizon usually makes the valuation estimate more stable and improves the predictive value of the methodology.
As an exchange-traded stock, Xilio Development derives its market value from live trading in the market. Market price and intrinsic value do not always move together, which can create an opportunity when the gap eventually narrows.
Historical Market  7.14 Real  7.89 Target  2.0 Hype  7.14 Naive  6.8
Estimating the real value of Xilio Development requires analyzing Xilio Development's future cash flows, earnings power, and asset base. Various approaches such as discounted cash flow, price-to-earnings, and price-to-book models can provide different perspectives on Xilio Development's intrinsic worth.
7.89
Real Value
10.72
Upside
Evaluating the potential upside and downside for Xilio Development helps investors build a more complete risk picture. A purely fundamental view of Xilio stock may understate important market and technical factors.
Earnings
Estimates
LowProjectedHigh
-0.14-0.14-0.14
Details
Hype
Prediction
LowEstimatedHigh
4.317.149.97
Details
Naive
Forecast
LowNext ValueHigh
3.976.809.63
Details
Analyst
Consensus
LowTarget PriceHigh
1.822.002.22
Details
Valuing Xilio Development requires understanding both its financial fundamentals and how the market prices similar businesses. The gap between intrinsic and market value is where investment opportunities are found.

Main Profitability Drivers

Xilio Development converts revenue at a -1.84% net margin rate, while its operating margin sits at -10.12%. The positive spread between net and operating margins suggests Xilio Development earns meaningful income outside its core operations. From 6.34 Million in revenue, Xilio Development retained 26.26 Million after cost of goods and reported -58.24 Million in net income. The company produces -9.08% on shareholders' equity and -26.26% on total assets, framing Xilio Development's capital efficiency picture. Deteriorating profitability trends for Xilio Development indicate that cost pressures or revenue weakness may be outpacing operational gains. Explore the full picture through Xilio Development's complete profitability review to assess how these metrics compare over time.
 Price Book
5.2438
 Gross Profit
26.3 M
 Price Sales
0.0842
 Profit Margin
-1.84
 Enterprise Value Revenue
1.9535
At present, Cash is showing a moving upward trajectory relative to prior years. As of the last annual report, Cash was 63.58 Million. As of earlier this week, Accounts Payable is projected to grow to approximately 2.4 M.

Xilio Development Cash

89.19 Million

Total Value Analysis

From a capital-structure perspective, Xilio Development is being framed with enterprise value of -59.03 M, market capitalization of 2.68 M, debt obligations near 8.14 M, and cash resources of 159.41 M. When enterprise value turns negative, investors usually need to test whether the market is pricing future growth too cautiously or whether liabilities and cash are distorting the surface read.
  Takeover PriceMarket CapDebt ObligationsCash
-59.03 M
2.68 M
8.14 M
159.41 M

Investor Information

About 35.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 8.54. Xilio Development had not issued any dividends in recent years. The company completed a 1:14 stock split on 16th of March 2026. Current financial indicators reflect structured asset utilization and capital deployment. Current profitability metrics are under pressure, reflecting a period of reduced earnings capacity. In technology businesses, recurring revenue quality, R&D investment discipline, and operating margin expansion are key durability indicators.

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Xilio Development has an asset utilization ratio of 8.93 percent. This suggests that the Company is making $0.0893 for each dollar of assets. An increasing asset utilization means that Xilio Development is more efficient with each dollar of assets it utilizes for everyday operations.
Macro event markers
 
Covid
 
Interest Hikes

Profitability Analysis

Based on Xilio Development's profitability indicators, Xilio Development may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in April. Profitability indicators assess Xilio Development's ability to earn profits and add value for shareholders.
 
Net Loss  
 First Reported
2020-03-31
 Previous Quarter
-15.8 M
 Current Value
-16.3 M
 Quarterly Volatility
4.1 M
Macro event markers
 
Covid
 
Interest Hikes
As of earlier this week, Gross Profit is projected to grow to approximately 7.7 M, whereas Pretax Profit Margin is moving lower toward -8.68 .
For Xilio Development profitability analysis, investors typically examine the ratios and operating drivers that show how well the company turns sales, assets, and shareholder capital into profit. Used properly, profitability analysis can show what is supporting performance today and what may begin to weaken it later.

Earnings per Share Projection vs Actual

By analyzing Xilio Development's earnings estimates, investors can diagnose trend shifts in analyst expectations and compare EPS projections across timeframes. EPS is most informative when read together with margin stability and cash-flow conversion. When reviewing projected earnings per share for Xilio Development, investors should keep in mind that consensus EPS estimates can include assumptions that smooth non-recurring items and stock-compensation effects. Xilio Development is projected to generate -0.14 in earnings per share on 31st of March 2026. The practical value of the EPS estimate is that it gives investors a benchmark for comparing reported results with the market's prior expectations.
Macro event markers
 
Covid
 
Interest Hikes

Ownership Allocation

Xilio Development reflects a sizeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. The 42% institutional stake in Xilio Development compares to 35% held by insiders and 22% by retail investors.

Revenue and Profit Overview

The company reported last year's revenue of 6.34 M. Reported Net Loss for the year was -58.24 M with profit before taxes, overhead, and interest of 26.26 M.
For Xilio Development, sound valuation work starts with a framework that tests assumptions, market expectations, and balance-sheet quality at the same time. Used correctly, valuation analysis can show whether the market may be too optimistic, too cautious, or simply inconsistent about the underlying business.

Valuation Framework, Methodology & Assumptions

Xilio Development is a micro-cap equity in Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care categories. Capital structure affects intrinsic modeling assumptions. Xilio Development currently trades at P/B of 5.24, P/S of 0.08.

Unless otherwise specified, data for Xilio Development is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day. Valuation outputs are model-derived and depend on published assumptions and reference inputs.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board
Last reviewed on March 7th, 2026

Xilio Development Current Valuation Indicators

Valuation analysis for Xilio Development is about estimating what the business is worth based on operating performance, asset quality, liabilities, and future earning power rather than on headline price alone. The business currently sits in the Healthcare sector and the Biotechnology industry. The goal is to judge whether the current price embeds too much optimism, too much caution, or a roughly fair view of the business.

More Resources for Xilio Stock Analysis

A structured review of Xilio Development often starts with core financial statements and trend context. Ratios and trend metrics help frame Xilio Development's operating context across reporting periods. Key reports that frame Xilio Development Stock are listed below:
Xilio Development has a market cap of 2.68 M, operating margin of -10.12%, ROE of -9.08%. Your Current Watchlist can help frame allocation decisions. This includes a position in Xilio Development within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Our How to Invest in Xilio Development guide provides practical guidance on trading Xilio Stock.
Xilio Development currently shows ROE of -9.08%, market cap of 2.68 Million. This analysis of Xilio Development works best as a complementary layer when evaluating how the security fits in a broader portfolio. Xilio Development analysis across multiple dimensions - risk, valuation, diversification - produces a more informed position-sizing decision. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
 Earnings Share
-8.54
 Revenue Per Share
0.614
 Quarterly Revenue Growth
7.425
 Return On Assets
-0.26
 Return On Equity
-9.08
Investors evaluate Xilio Development using market value and book value, each describing different facets of the business. Xilio Development's market capitalization is 2.68 M. At P/B 5.24, Xilio Development trades at a significant premium to book value. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Value and price for Xilio Development are related but not identical, and they can diverge across cycles. For Xilio Development, key inputs include a P/B ratio of 5.24, a profit margin of -1.84%, ROE of -9.08%, and revenue of 6.34 M. The quoted Xilio Development price is the exchange level where supply meets demand.